Literature DB >> 11107502

X-linked hyper IgM syndrome.

L C Schneider1.   

Abstract

X-linked hyper IgM syndrome is largely caused by defects in the CD40L (CD154). The patients have low levels of IgG and have difficulty with respiratory infections as well as opportunistic infections. The morbidity of this syndrome is high; however, early diagnosis and therapy should reduce morbidity and mortality.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11107502     DOI： 10.1385/CRIAI:19:2:205

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN： 1080-0549            Impact factor:   10.817


  56 in total

1.  Development of a rapid whole blood flow cytometry procedure for the diagnosis of X-linked hyper-IgM syndrome patients and carriers.

Authors:  M R O'Gorman; D Zaas; M Paniagua; V Corrochano; P R Scholl; L M Pachman
Journal:  Clin Immunol Immunopathol       Date:  1997-11

Review 2.  Molecular pathology of X-linked immunoglobulin deficiency with normal or elevated IgM (HIGMX-1).

Authors:  N Ramesh; R Fuleihan; R Geha
Journal:  Immunol Rev       Date:  1994-04       Impact factor: 12.988

3.  Brief report: prenatal diagnosis of X-linked hyper-IgM syndrome.

Authors:  J P DiSanto; S Markiewicz; J F Gauchat; J Y Bonnefoy; A Fischer; G de Saint Basile
Journal:  N Engl J Med       Date:  1994-04-07       Impact factor: 91.245

4.  An evolving view of hyper-IgM syndrome.

Authors:  M E Conley
Journal:  J Pediatr       Date:  1997-07       Impact factor: 4.406

5.  CD40 ligand is required for protective cell-mediated immunity to Leishmania major.

Authors:  K A Campbell; P J Ovendale; M K Kennedy; W C Fanslow; S G Reed; C R Maliszewski
Journal:  Immunity       Date:  1996-03       Impact factor: 31.745

6.  Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells.

Authors:  F M Uckun; K Gajl-Peczalska; D E Myers; W Jaszcz; S Haissig; J A Ledbetter
Journal:  Blood       Date:  1990-12-15       Impact factor: 22.113

7.  Structural organization of the gene for CD40 ligand: molecular analysis for diagnosis of X-linked hyper-IgM syndrome.

Authors:  M Shimadzu; H Nunoi; H Terasaki; R Ninomiya; M Iwata; S Kanegasaka; I Matsuda
Journal:  Biochim Biophys Acta       Date:  1995-01-02

8.  CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency.

Authors:  M Farrington; L S Grosmaire; S Nonoyama; S H Fischer; D Hollenbaugh; J A Ledbetter; R J Noelle; A Aruffo; H D Ochs
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-01       Impact factor: 11.205

9.  CD40 ligand is required for resolution of Pneumocystis carinii pneumonia in mice.

Authors:  J A Wiley; A G Harmsen
Journal:  J Immunol       Date:  1995-10-01       Impact factor: 5.422

10.  CD40lbase: a database of CD40L gene mutations causing X-linked hyper-IgM syndrome.

Authors:  L D Notarangelo; M C Peitsch; T G Abrahamsen; C Bachelot; P Bordigoni; A J Cant; H Chapel; M Clementi; S Deacock; G de Saint Basile; M Duse; T Espanol; A Etzioni; A Fasth; A Fischer; S Giliani; L Gomez; L Hammarstorm; A Jones; M Kanariou; C Kinnon; T Klemola; R A Kroczek; J Levy; N Matamoros; V Monafo; P Paolucci; I Reznick; O Sanal; C I Smith; R A Thompson; P Tovo; A Villa; M Vihinen; J Vossen; B J Zegers
Journal:  Immunol Today       Date:  1996-11
View more
  3 in total

Review 1.  Prospects for modulating the CD40/CD40L pathway in the therapy of the hyper-IgM syndrome.

Authors:  Xiangxue Meng; Bin Yang; Wen-Chen Suen
Journal:  Innate Immun       Date:  2017-11-13       Impact factor: 2.680

2.  CD40 agonist antibody mediated improvement of chronic Cryptosporidium infection in patients with X-linked hyper IgM syndrome.

Authors:  Xiying Fan; Bhaskar Upadhyaya; Liming Wu; Christopher Koh; Mónica Santín-Durán; Stefania Pittaluga; Gulbu Uzel; David Kleiner; Ester Williams; Chi A Ma; Aaron Bodansky; Joao B Oliveira; Pamela Edmonds; Ronald Hornung; Duane W Wong; Ronald Fayer; Tom Fleisher; Theo Heller; Calman Prussin; Ashish Jain
Journal:  Clin Immunol       Date:  2012-02-07       Impact factor: 3.969

3.  Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand.

Authors:  Ashish Jain; Joseph A Kovacs; David L Nelson; Stephen A Migueles; Stefania Pittaluga; William Fanslow; Xiying Fan; Duane W Wong; Justin Massey; Ronald Hornung; Margaret R Brown; Jacob J Spinner; Shuying Liu; Victoria Davey; Harry A Hill; Hans Ochs; Thomas A Fleisher
Journal:  Blood       Date:  2011-08-12       Impact factor: 22.113
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.